Wolverine Asset Management’s Aratana Therapeutics, Inc. PETX Stock Holding History

Wolverine Asset Management’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-5,676	Closed	-$29K	–	1745
2019 Q2	$29K	Buy	+5,676	New	+$25.5K	﹤0.01%	1248

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Wolverine Asset Management's PETX Position: Q3 2019 in Review

Wolverine Asset Management sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 5,676 shares — an estimated $29K sold.

Wolverine Asset Management first reported a position in PETX in Q2 2019 and held it in 1 quarter. The position peaked at $29K in Q2 2019. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

Wolverine Asset Management reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Wolverine Asset Management sold 5,676 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $29K.
Wolverine Asset Management first reported a position in Aratana Therapeutics, Inc. in Q2 2019 and held it in 1 quarter.
Wolverine Asset Management's Aratana Therapeutics, Inc. position peaked at $29K in Q2 2019.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Wolverine Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.